M&A Deal Summary |
|
|---|---|
| Date | 2024-12-19 |
| Target | Sherlock Biosciences |
| Sector | Life Science |
| Buyer(s) | OraSure Technologies |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Medical Products |
| Employees | 638 |
| Revenue | 186M USD (2024) |
OraSure Technologies provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services. OraSure Technologies was founded in 2000 and is based in Bethlehem, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Massachusetts M&A | 2 of 2 |
| Country: United States M&A | 2 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-29 |
UrSure
Boston, Massachusetts, United States UrSure, Inc. has developed a series of tests to measure and improve adherence to medications for HIV prevention and treatment. The company has received millions of dollars in NIH Small Business Innovation Research funding and commercialized the world’s first test for PrEP and HIV treatment adherence, which is in use in clinics nationwide. UrSure was formed in 2015 and is based in Boston, Massachusetts. |
Buy | - |
